Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Dec 15;186(12):1352-1361.
doi: 10.1093/aje/kwx235.

TMPRSS2:ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-Analysis of Racial Differences

Cindy Ke Zhou  1 , Denise Young  2 , Edward D Yeboah  3 , Sally B Coburn  1 , Yao Tettey  3 , Richard B Biritwum  3 , Andrew A Adjei  3 , Evelyn Tay  3 , Shelley Niwa  4 , Ann Truelove  4 , Judith Welsh  5 , James E Mensah  3 , Robert N Hoover  6 , Isabell A Sesterhenn  7 , Ann W Hsing  8   9 , Shiv Srivastava  2 , Michael B Cook  1
Affiliations
Meta-Analysis

TMPRSS2:ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-Analysis of Racial Differences

Cindy Ke Zhou et al. Am J Epidemiol. .

Abstract

The prevalence of fusions of the transmembrane protease, serine 2, gene (TMPRSS2) with the erythroblast transformation-specific-related gene (ERG), or TMPRSS2:ERG, in prostate cancer varies by race. However, such somatic aberration and its association with prognostic factors have neither been studied in a West African population nor been systematically reviewed in the context of racial differences. We used immunohistochemistry to assess oncoprotein encoded by the ERG gene as the established surrogate of ERG fusion genes among 262 prostate cancer biopsies from the Ghana Prostate Study (2004-2006). Poisson regression with robust variance estimation provided prevalence ratios and 95% confidence intervals of ERG expression in relation to patient characteristics. We found that 47 of 262 (18%) prostate cancers were ERG-positive, and being negative for ERG staining was associated with higher Gleason score. We further conducted a systematic review and meta-analysis of TMPRSS2:ERG fusions in relation to race, Gleason score, and tumor stage, combining results from Ghana with 40 additional studies. Meta-analysis showed the prevalence of TMPRSS2:ERG fusions in prostate cancer to be highest in men of European descent (49%), followed by men of Asian (27%) and then African (25%) descent. The lower prevalence of TMPRSS2:ERG fusions in men of African descent implies that alternative genomic mechanisms might explain the disproportionately high prostate cancer burden in such populations.

Keywords: TMPRSS2:ERG; West Africa; prostatic neoplasms; racial differences; systematic review.

PubMed Disclaimer

References

    1. Odedina FT, Akinremi TO, Chinegwundoh F, et al. . Prostate cancer disparities in black men of African descent: a comparative literature review of prostate cancer burden among black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer. 2009;4(suppl 1):S2. - PMC - PubMed
    1. Wong MC, Goggins WB, Wang HH, et al. . Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries. Eur Urol. 2016;70(5):862–874. - PubMed
    1. Tan DS, Mok TS, Rebbeck TR. Cancer genomics: diversity and disparity across ethnicity and geography. J Clin Oncol. 2016;34(1):91–101. - PubMed
    1. Ateeq B, Bhatia V, Goel S. Molecular discriminators of racial disparities in prostate cancer. Trends Cancer. 2016;2(3):116–120. - PMC - PubMed
    1. Khani F, Mosquera JM, Park K, et al. . Evidence for molecular differences in prostate cancer between African American and Caucasian men. Clin Cancer Res. 2014;20(18):4925–4934. - PMC - PubMed